Navigation Links
A splice of the action: Translational role for WT1 isoform

In the June 15th issue of G&D, Dr. Marie-Louise Hammarskjold (UVA) and colleagues lend new insight into the function of the Wilms' Tumor 1 tumor suppressor. The Wilms' Tumor 1 (WT1) protein is important to both normal and pathological human development, with known roles in kidney and urogenital formation as well as several human cancers.

Dr. Hammarskjold and colleagues reveal that WT1 works not only at the transcriptional level, but also at the post-transcriptional level to regulate gene expression. The WT1 gene encodes two major alternatively spliced protein isoforms: WT1(+KTS) and WT1(-KTS). While WT1(-KTS) has an established role as a DNA-binding transcription factor, the function of WT1(+KTS) has been elusive.

Dr. Hammarskjold's team now show that WT1(+KTS) promotes translation of target mRNAs by aiding in the transport and cytoplasmic stability of unspliced, intron-containing mRNA. Dr. Hammarskjold explains that "the general impact of this study is that it highlights the links that exist between transcription and post-transcriptional gene regulation and the importance of alternative splicing. We hope that these results will stimulate further studies to identify genes that are regulated by WT1 at the translational level and the role that this type of regulation plays in normal development and disease."


'"/>

Source:Cold Spring Harbor Laboratory


Page: 1

Related biology news :

1. Products containing specific probes for detecting alternative splice forms protected
2. Gut reaction: Researchers define the colons genome
3. Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/20/2016)... LONDON , Dec. 20, 2016 ... car sharing, rental and leasing is stoking significant ... of radio frequency technology, Bluetooth low energy (BLE), ... emerge as the next wave of wireless technologies ... vehicle access system to advanced access systems opens ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
(Date:12/15/2016)... ... has announced the addition of the "Global Military Biometrics Market 2016-2020" ... global military biometrics market to grow at a CAGR of 7.5% during ... on an in-depth market analysis with inputs from industry experts. The report ... The report also includes a discussion of the key vendors operating in ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... PARSIPPANY, N.J. , Jan. 20, 2017 /PRNewswire/ ... the "Company"), a company that provides clinically useful ... that it has entered into a securities purchase ... aggregate of 855,000 shares of common stock in ... placement, the Company has agreed to sell to ...
(Date:1/21/2017)... Jan. 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: ... on the licensing, development and commercialization of innovative biopharmaceutical ... Best Company in North America ... award based on the FDA approval of three ... ENTYCE ® (capromorelin oral solution) and NOCITA ® ...
(Date:1/20/2017)... ... , ... The two newest companies to join the University City Science Center’s ... from The Wistar Institute, and Sanguis, launched by a trio of students from the ... Vironika is developing a treatment for a chronic viral infection and its associated diseases, ...
(Date:1/20/2017)... Jan. 20, 2017 Ginkgo Bioworks, the ... a pioneer in the synthesis and assembly of ... in assembling pathway-length synthetic DNA into Ginkgo,s automated ... in the construction of new organism designs for ... "Gen9 was founded to significantly increase the ...
Breaking Biology Technology: